Exelixis (EXEL)
(Real Time Quote from BATS)
$26.32 USD
-0.10 (-0.38%)
Updated Sep 23, 2024 10:34 AM ET
3-Hold of 5 3
B Value C Growth A Momentum A VGM
Exelixis (EXEL) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$27.90 | $33.00 | $23.00 | 5.60% |
Price Target
Based on short-term price targets offered by 20 analysts, the average price target for Exelixis comes to $27.90. The forecasts range from a low of $23.00 to a high of $33.00. The average price target represents an increase of 5.6% from the last closing price of $26.42.
Analyst Price Targets (20)
Broker Rating
Exelixis currently has an average brokerage recommendation (ABR) of 1.62 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 21 brokerage firms. The current ABR compares to an ABR of 1.55 a month ago based on 20 recommendations.
Of the 21 recommendations deriving the current ABR, 14 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 66.67% and 4.76% of all recommendations. A month ago, Strong Buy made up 70%, while Buy represented 5%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 14 | 14 | 14 | 14 | 14 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 6 | 5 | 5 | 5 | 5 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.62 | 1.55 | 1.55 | 1.55 | 1.55 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/19/2024 | UBS | Ashwani Verma | Not Available | Hold |
9/18/2024 | H.C. Wainwright & Co. | Robert Burns | Strong Buy | Strong Buy |
9/8/2024 | BMO Capital Markets | Etzer Darout | Strong Buy | Strong Buy |
9/5/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/28/2024 | Guggenheim Securities | Michael Schmidt | Strong Buy | Strong Buy |
8/12/2024 | Wells Fargo Securities | Derek C Archila | Strong Buy | Strong Buy |
8/7/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
8/7/2024 | JMP Securities | Silvan C Tuerkcan | Strong Buy | Strong Buy |
8/7/2024 | Truist Securities | Asthika S Goonewardene | Strong Buy | Strong Buy |
8/6/2024 | Piper Sandler | Joseph M Catanzaro | Strong Buy | Strong Buy |
8/6/2024 | Not Identified | Not Identified | Hold | Hold |
7/30/2024 | Not Identified | Not Identified | Hold | Hold |
7/24/2024 | SVB Securities | Andrew Berens | Hold | Hold |
5/14/2024 | Stephens | Sudan Loganathan | Strong Buy | Hold |
5/1/2024 | William Blair | Andy T Hsieh | Strong Buy | Strong Buy |
5/1/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
4/1/2024 | Cowen & Co. | Yaron Werber | Strong Buy | Strong Buy |
12/19/2023 | BTIG | Kaveri Pohlman | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.62 |
ABR (Last week) | 1.55 |
# of Recs in ABR | 21 |
Average Target Price | $27.90 |
LT Growth Rate | 29.80% |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 79 of 253 |
Current Quarter EPS Est: | 0.42 |
EXEL FAQs
Exelixis, Inc. (EXEL) currently has an average brokerage recommendation (ABR) of 1.62 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 21 brokerage firms.
The average price target for Exelixis, Inc. (EXEL) is $27.90. The current on short-term price targets is based on 11 reports.
The forecasts for Exelixis, Inc. (EXEL) range from a low of $23 to a high of $33. The average price target represents a increase of $5.60 from the last closing price of $26.42.
The current UPSIDE for Exelixis, Inc. (EXEL) is 5.60%
Based on short-term price targets offered by 20 analysts, the average price target for Exelixis comes to $27.90. The forecasts range from a low of $23.00 to a high of $33.00. The average price target represents an increase of 5.6% from the last closing price of $26.42.